There is no effective vaccine currently available to prevent Lyme disease in humans. Experts from academia, government, and industry recently convened to tackle this public health challenge. Now, a new article reiterates the need to stop the infection, and defines a strategy for developing effective vaccines.
Read moreA study describes a new rapid assay for Lyme disease that could lead to a practical test for use by healthcare providers. The researchers found the assay, which uses several biomarkers to detect Lyme disease infection, was more sensitive than current laboratory-based tests when diagnosing Lyme disease early after suspected infection.
Read moreCurrent testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret. Biomedical engineers have developed a rapid microfluidic test that can detect Lyme disease with similar performance as the STT in a much shorter time — 15 minutes.
Read moreScientists reported on the prevalence of multiple agents capable of causing human disease that are present in three species of ticks in Long Island.
Read more